ResearcherHumboldt-Universität zu BerlinActive in the last 2 years
Uli Fehrenbach
Matched on ORCID iD 0000-0003-3622-3268; OpenAlex author ID A5067851340. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2022: 2 papers · 2023: 2 papers · 2024: none · 2025: none · 2026: 2 papers
Papers 6
- Federated CT foundation models for multi-center detection of lymph node metastasis in pancreatic cancer. Co-author DOI 10.1038/s41598-026-47631-2↗
- Virtual reality volumetric rendering versus cross-sectional imaging for pancreatic cancer resectability assessment: a pilot randomized controlled reader study. Co-author DOI 10.1186/s42234-026-00202-2↗
- Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients-A Single Center Analysis of 2323 Patien… Co-author DOI 10.3390/jcm12113656↗
- Correction: Felsenstein M. et al. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies? J. Clin. Med. 2022… Co-author DOI 10.3390/jcm12216947↗
- Influence of Baseline CT Body Composition Parameters on Survival in Patients with Pancreatic Adenocarcinoma. Last author DOI 10.3390/jcm11092356↗
- Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies? Co-author DOI 10.3390/jcm11092367↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Thomas Malinka · 5 shared papers, 2022–2026 · strength 0.87
- Paper Virtual reality volumetric rendering versus cross-sectional imaging for pancreatic cancer resectability assessment: a p… DOI 10.1186/s42234-026-00202-2↗
- Paper Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients… DOI 10.3390/jcm12113656↗
- Paper Influence of Baseline CT Body Composition Parameters on Survival in Patients with Pancreatic Adenocarcinoma. DOI 10.3390/jcm11092356↗
- Matthäus Felsenstein · 4 shared papers, 2022–2026 · strength 0.83
- Paper Federated CT foundation models for multi-center detection of lymph node metastasis in pancreatic cancer. DOI 10.1038/s41598-026-47631-2↗
- Paper Virtual reality volumetric rendering versus cross-sectional imaging for pancreatic cancer resectability assessment: a p… DOI 10.1186/s42234-026-00202-2↗
- Paper Correction: Felsenstein M. et al. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curativ… DOI 10.3390/jcm12216947↗
- Uwe Pelzer · 4 shared papers, 2022–2023 · strength 0.61
- Paper Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients… DOI 10.3390/jcm12113656↗
- Paper Influence of Baseline CT Body Composition Parameters on Survival in Patients with Pancreatic Adenocarcinoma. DOI 10.3390/jcm11092356↗
- Paper Correction: Felsenstein M. et al. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curativ… DOI 10.3390/jcm12216947↗
- Lea Timmermann · 3 shared papers, 2022–2026 · strength 0.54
- Paper Virtual reality volumetric rendering versus cross-sectional imaging for pancreatic cancer resectability assessment: a p… DOI 10.1186/s42234-026-00202-2↗
- Paper Correction: Felsenstein M. et al. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curativ… DOI 10.3390/jcm12216947↗
- Paper Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies? DOI 10.3390/jcm11092367↗
- Christian Benzing · 3 shared papers, 2022–2023 · strength 0.46
- Paper Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients… DOI 10.3390/jcm12113656↗
- Paper Correction: Felsenstein M. et al. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curativ… DOI 10.3390/jcm12216947↗
- Paper Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies? DOI 10.3390/jcm11092367↗
- Christopher Neumann · 2 shared papers, 2022–2023 · strength 0.33
- Parinishtha Bhalla · 1 shared paper, 2026 · strength 0.29
- Alexander Semaan · 1 shared paper, 2026 · strength 0.29
- Shadi Albarqouni · 1 shared paper, 2026 · strength 0.29
- Bruno Valentin Sinn · 2 shared papers, 2022–2023 · strength 0.28
- Mengwen Hu · 2 shared papers, 2022–2023 · strength 0.28
- Moritz Queisner · 1 shared paper, 2026 · strength 0.26
- Karl Eisenträger · 1 shared paper, 2026 · strength 0.26
- Benjamin Struecker · 1 shared paper, 2026 · strength 0.26
- François Schneider · 1 shared paper, 2023 · strength 0.17
- Timo Alexander Auer · 1 shared paper, 2022 · strength 0.16
- Nick Lasse Beetz · 1 shared paper, 2022 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.